Live feed
Filing
SC 13G
SC 13G0001019056-21-000312·PhaseBio Pharmaceuticals Inc
Schedule 13G ownership disclosure
PHASEBIO PHARMACEUTICALS INC
Security class unavailable · CUSIP: 717224109
Event date: 2021-05-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-21-000312
- Form type
- SC 13G
- Filer
- PhaseBio Pharmaceuticals Inc
- CIK
- CIK 1169245
- Filed
- May 19, 2021
- Reporting period
- May 12, 2021
- Description
- Schedule 13G beneficial ownership